What is the problematic aspect for the patient of employing a platform that fails to detect an actionable molecular alteration?

What is the problematic aspect for the patient of employing a platform that fails to detect an actionable molecular alteration?

What is the problematic aspect for the patient of employing a platform that fails to detect an actionable molecular alteration?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Prof. Matthew Krebs, MD, PhD

Prof. Matthew Krebs, MD, PhD

Clinical Senior Lecturer
Experimental Cancer Medicine
Honorary Consultant
Medical Oncology
The University of Manchester
Greater Manchester, UK